-

Veradigm Inc. Reminder: Robbins LLP is Investigating MDRX on Behalf of Investors

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating Veradigm Inc. (NASDAQ: MDRX) to determine whether certain Veradigm officers and directors violated securities laws and breached fiduciary duties to shareholders. Veradigm is a healthcare technology company that provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally.

What Now: Veradigm Inc. shareholders have legal options. If you own shares of Veradigm Inc. and have lost money in your investment, contact us for more information about your rights.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas, Jr.
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: Some law firms issuing releases about this matter do not actually litigate securities class actions; Robbins LLP does. A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. Since our inception, we have obtained over $1 billion for shareholders.

To be notified if a class action against Veradigm Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:MDRX

Release Summary
Veradigm Inc. Reminder: Robbins LLP is Investigating MDRX on Behalf of Investors
Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

REGN Stock Drop: If You Lost Money Investing in Regeneron Pharmaceuticals, Inc. Contact Robbins LLP for Information About Leading the Class Action Lawsuit

SAN DIEGO, Calif.--(BUSINESS WIRE)--Robbins LLP reminds investors that a securities class action has been filed on behalf of investors who purchased or otherwise acquired Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between August 1, 2025 and May 15, 2026, inclusive (the “Class Period”). The lawsuit alleges that Regeneron Pharmaceuticals misled investors regarding the viability and prospects of its Phase 3 Fianlimab-Libtayo clinical trial for patients with advanced melanoma. Invest...

Shareholder Alert - Robbins LLP Informs Investors of the Pentair plc Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Pentair plc (NYSE: PNR) securities between April 28, 2026 and July 14, 2026 (the "Class Period"). Pentair provides various water solutions, such as filtration, water supply pumps, and fluid treatment products. The lawsuit alleges that Pentair plc misled investors regarding the destocking of its inventory in the Pool ch...

Stockholder Alert: Robbins LLP Informs Investors of the Alibaba Group Holding Limited (BABA) Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Alibaba Group Holding Limited (NYSE:BABA) between June 26, 2025 and June 24, 2026 (the "Class Period"). The complaint alleges that Alibaba failed to inform investors that it was considered a Chinese military company and that it was at risk of being impacted by the U.S.'s crackdown on Chinese military compani...
Back to Newsroom